Lentiviruses are non-oncogenic retroviruses which cause chronic progressive neurological diseases with unusually long incubation periods. Visna virus in sheep and caprine-arthritis-encephalitis-virus (CAEV) in goats, are the prototypes of this group of viruses, which in addition to the progressive neurological disease cause chronic pneumonitis and arthritis. These viruses cause persistent infections in vivo, replicating at a slow but continuous rate; they have pathogenic potential in vitro causing syncytia and cell lysis and replicate at a rapid and highly productive level. It has recently been shown that visna virus and CAEV are related to the human-T-cell lymphotropic virus type III (HTLV-III), the presumptive agent of AIDS. HTLV-III and the lentiviruses are morphologically indistinguishable, share considerable nucleotide sequence homology and cause neurological disease. The ability of the lentiviruses to replicate to high titer in vitro suggests that they have a high level of gene expression. However, during persisting infection in vivo gene expression appears to be down regulated by multiple factors including viral genetic elements, a unique lentivirus induced interferon and the stage of differentiation of the target cell.
The aim of this proposal is to study the mechanisms of gene regulation which cause restricted replication in vivo. In particular, the cis- and trans-acting regulatory elements in the LTRs of these viruses will be studied to determine their roles in both positive and negative regulation. The mechanism of induction of the lentivirus induced interferon will be studied to determine the lentivirus signal. The step in viral replication which is restricted by this unique interferon will be determined. Finally, the basis for latency of the lentiviruses in monocytes will be studied to determine the state at which virus replication is restricted and the role of cellular and viral elements in this restriction.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS023039-03
Application #
3406038
Study Section
Experimental Virology Study Section (EVR)
Project Start
1986-07-01
Project End
1990-03-31
Budget Start
1988-07-01
Budget End
1990-03-31
Support Year
3
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Barber, Sheila A; Herbst, David S; Bullock, Brandon T et al. (2004) Innate immune responses and control of acute simian immunodeficiency virus replication in the central nervous system. J Neurovirol 10 Suppl 1:15-20
Rue, Sarah M; Roos, Jason W; Amzel, L Mario et al. (2003) Hydrogen bonding at a conserved threonine in lentivirus capsid is required for virus replication. J Virol 77:8009-18
Barber, Sheila A; Bruett, Linda; Douglass, Brian R et al. (2002) Visna virus-induced activation of MAPK is required for virus replication and correlates with virus-induced neuropathology. J Virol 76:817-28
Bruett, L; Clements, J E (2001) Functional murine leukemia virus vectors pseudotyped with the visna virus envelope show expanded visna virus cell tropism. J Virol 75:11464-73
Bruett, L; Barber, S A; Clements, J E (2000) Characterization of a membrane-associated protein implicated in visna virus binding and infection. Virology 271:132-41
Barber, S A; Bruett, L; Clements, J E (2000) Involvement of a membrane-associated serine/threonine kinase complex in cellular binding of visna virus. Virology 274:321-30
Morse, B A; Carruth, L M; Clements, J E (1999) Targeting of the visna virus tat protein to AP-1 sites: interactions with the bZIP domains of fos and jun in vitro and in vivo. J Virol 73:37-45
Craig, L E; Sheffer, D; Meyer, A L et al. (1997) Pathogenesis of ovine lentiviral encephalitis: derivation of a neurovirulent strain by in vivo passage. J Neurovirol 3:417-27
Schoborg, R V; Clements, J E (1996) Definition of the RRE binding and activation domains of the caprine arthritis encephalitis virus Rev protein. Virology 226:113-21
Carruth, L M; Morse, B A; Clements, J E (1996) The leucine domain of the visna virus Tat protein mediates targeting to an AP-1 site in the viral long terminal repeat. J Virol 70:4338-44

Showing the most recent 10 out of 38 publications